In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations

Hybridoma

Volumn 30, Issue 5, 2011, Pages 409-418

  Daftarian, Pirouz ^a,b   Chowdhury, Raquibul ^b   Ames, Philip ^a   Wei, Changli ^b   King, Alan D ^d   De Rivero Vaccari, Juan Pablo ^a   Dillon, Lloye ^a   Price, Justin ^a   Leung, Howard ^a   Ashlock, Brittany ^a   Mesri, Enrique ^a   Perez, Victor ^a   Züchner, Stephan ^b   Reiser, Jochen ^b   Lemmon, Vance ^c   Keane, Robert W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d Arvid Wallgrens Backe 20   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; INTERFERON REGULATORY FACTOR 1; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 7; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PLASMID DNA;

ANIMAL EXPERIMENT; ARTICLE; CELL PERMEABILIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROPORATION; FEMALE; GENETIC TRANSFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; ELECTROPORATION; FEMALE; HEK293 CELLS; HUMANS; IMMUNE SERA; LEUKOCYTE L1 ANTIGEN COMPLEX; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; OVALBUMIN; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEINS; VACCINES, DNA;

EID: 80054970542     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2010.0120     Document Type: Article

References (35)

1. Reichert J, and Pavolu A: Monoclonal antibodies market. Nat Rev Drug Discov 2004;3:383-384.
2. Walls D, McGrath R, and Loughran ST: A digest of protein purification. [review]. Methods Mol Biol 2011;681:3-23.
3. Burgess RR: Refolding solubilized inclusion body proteins. In: Guide to Protein Purification, 2nd ed. Burgess RR, and Deut-scher, MP (Eds.). Academic Press, San Diego, 2009, p. 463.
4. Lin S-H, and Guidotti G: Purification of membrane proteins. In: Guide to Protein Purification, 2nd ed. Burgess RR, and Deutscher, MP (Eds.). Academic Press, San Diego, 2009, p. 463.
5. Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, and Nabel GJ: Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 5995;329:1060-1064.
6. Andre F, and Mir L: DNA electrotransfer: its principles and an updated review of its therapeutic applications [review]. Gene Ther 2004;11.
7. Cantelli CP, Teixeira M da Gloria Martins, Santos EA, Silva HC da, Mouta S da Silva E, Pimenta MM, Vianna CO, Souza NP de, Batoreu NM, Galler R, and de Moraes MT: Generation of monoclonal antibodies against human recombinant interferon beta using genetic immunization with simultaneous expression of IgM and IgG isotypes. Hybridoma 2009;28:211-214.
8. Chua KY, Ramos JD, and Cheong N: Production of monoclonal antibody by DNA immunization with electropora-tion. Methods Mol Biol 2008;423:509-520.
9. Ahmad S, Casey G, Sweeney P, Tangney M, and O'Sullivan G: Optimised electroporation mediated DNA vaccination for treatment of prostate cancer. Genet Vacc Ther 2010;8:1.
10. Kong W, Hood C, Yang Z, Wei C-J, Xu L, Garćia-Sastre A, Tumpey TM, and Nabel GJ: Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci 2006;103:15987-15991. (Pubitemid 44657579)
11. Chu TH, Yazdanbakhsh K, Oyen R, Smart E, and Reid EM: Production and characterization of anti-kell monoclonal antibodies using transfected cells as the immunogen. Br J Haematol 1999;106:817-823. (Pubitemid 29434228)
12. Buchan S, Gronevik E, Mathiesen I, King CA, Stevenson FK, and Rice J: Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. J Immunol 6292;174:6292-6298.
13. Bates MK, Zhang G, Sebestyen MG, Neal ZC, Wolff JA, and Herweijer H: Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Biotechniques 2006;40:199-208. (Pubitemid 46542641)
14. Moeller S, Jung C, Adriouch S, Dubberke G, Seyfried F, Seman M, Haag F, and Koch-Nolte F: Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation. Purinergic Signal 2007;3:359-366.
15. Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, Foster AC, and Lechner SM: A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phos-phorylation. J Biomol Screen 2006;11:351-358. (Pubitemid 43846335)
16. Hlavin ML, and Lemmon V: Molecular structure and functional testing of human L1CAM: an interspecies comparison. Genomics 1991;11:416-423.
17. Roos AK, Eriksson F, Timmons JA, Gerhardt J, Nyman U, Gudmundsdotter L, Brave A, Wahren B, and Pisa P: Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 7226;4.
18. Feng H, Sun Z, Farzan MR, and Feng P: Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation. J Virol 3351;84:3351-3361.
19. Harris FJ, Hawley GR, Hawley ST, and Crawford-Sharpe CG: Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant Il-6. J Immunol Methods 1992;148:199-207.
20. Chua KY, Ramos JD, and Cheong N: Production of monoclonal antibody by DNA immunization with electropora-tion. Methods Mol Biol 2008;423:509-520.
21. Chiarella P, Massi E, Robertis M De, Sibilio A, Parrella P, Fazio VM, and Signori E: Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Therapy 1645;8:1645-1657.
22. Wei C, Moller CC, Altintas AA, Li L, Schwarz K, Zacchigna S, XieL,HengerA,SchmidH,Rastaldi MP, CowanP,Kretzler M, Parrilla K, Bendayan M, Gupta V, Nikolic B, Kalluri R, Car-melietP,MundelP,and ReiserJ: Modificationofkidney barrier function by the urokinase receptor. Nat Med 2008;14:55-63.
23. Hendriksen CF, and de Leeuw W: Production of monoclonal antibodies by the ascites method in laboratory animals [review]. Res Immunol 1998;149:535-542. (Pubitemid 29486820)
24. Holloway JN, Murthy S, and El-Ashry D: A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB. Mol Endocrinol 2004;18:1396-1410. (Pubitemid 38692178)
25. Cheng J, Waite AL, Tkaczyk ER, Ke K, Richards N, Hunt AJ, and Gumucio DL: Kinetic properties of ASC protein aggregation in epithelial cells. J Cell Physiol 2010;222:738-747.
26. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, and Yang XF: Inflammasomes are differentially expressed in cardiovascular and other tissues. Intl J Immunopathol Pharmacol 2009;22:311-322.
27. Tekippe EM, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, Sandor M, Braunstein M, and Ting JP: Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS One 2010;5.
28. Montague P, Kennedy PG, and Barnett SC: Subcellular localization of Mayven following expression of wild type and mutant EGFP tagged cDNAs. BMC Neurosci 2010;11.
29. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, and Reiser J: Modification of kidney barrier function by the urokinase receptor. Nat Med 2008;14:55-63.
30. Zuchner S, Wang G, Tran-Viet KN, Nance MA, Gaskell PC, Vance JM, Ashley-Koch AE, and Pericak-Vance MA: Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genetics 2006;79:365-369. (Pubitemid 44141835)
31. Park SH, Zhu PP, Parker RL, and Blackstone C: Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J Clin Invest 1097;120:1097-1110.
32. Masuko T, Ohno Y, Masuko K, Yagi H, Uejima S, Takechi M, and Hashimoto Y: Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein [review]. Cancer Sci 2011;102:25-35.
33. Pozharskaya VP, Weakland LL, Zimring JC, Krug LT, Unger ER, Neisch A, Joshi H, Inoue N, and Offermann MK: Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells. J Virol 2004;78:6621-6635. (Pubitemid 38715958)
34. Howarth M, and Elliott T: The processing of antigens delivered as DNA vaccines. Immunol Rev 2004;199:27-39. (Pubitemid 38736762)
35. Cai Y, Rodriguez R, and Hebel H: DNA vaccine manufacture: scale and quality [review]. Expert Rev Vacc 1277;8:1277-1291.